New England Biotech Headlines
Today is November 08, 2009. All times in Eastern Time.
11/07/2009 - 07:00 AM
DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
11/06/2009 - 01:00 PM
Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council
11/06/2009 - 08:30 AM
Genetix Pharmaceuticals Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)
11/06/2009 - 08:00 AM
GTC Biotherapeutics Reports Third Quarter 2009 Financial Results
11/06/2009 - 07:30 AM
TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post
11/06/2009 - 07:15 AM
RXi Pharmaceuticals Appoints Noah D. Beerman as CEO
11/06/2009 - 07:13 AM
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
11/05/2009 - 05:18 PM
Accellent Inc. Announces Timing of Third Quarter 2009 Earnings Release and Conference Call
11/05/2009 - 04:43 PM
FDA Approves Gloucester Pharmaceuticals’ ISTODAX® for Patients with Cutaneous T-cell Lymphoma
11/05/2009 - 04:05 PM
Targacept Reports Third Quarter 2009 Financial Results
11/05/2009 - 04:03 PM
Millipore Reports Third Quarter 2009 Financial Results
11/05/2009 - 04:00 PM
Alkermes Reports Second Quarter Fiscal 2010 Financial Results
11/05/2009 - 02:47 PM
Alexion to Present at Credit Suisse’s 2009 Healthcare Conference
11/05/2009 - 02:39 PM
AdvanSource Biomaterials Files Patent for Silicone-Urethane Copolymers
11/05/2009 - 12:04 PM
Celldex Therapeutics to Present at Merriman Curhan Ford’s Investor Summit 2009
1
2
3
4
5
Next »
About Us
|
Contact Us
|
Privacy Statement
|
Terms of Use
|
© Business Wire 2009